0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover0.00%IV-371.70%PremiumDec 20, 2024Expiry Date3.94Intrinsic Value100Multiplier20DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.33Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Connect Biopharma Stock Discussion
NEWS
Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma
Price target for this stock is 7$ its undervalued .. sooner it will jump to 2.5 to 3$
No comment yet